zalcitabine has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copaceanu, ML; Cottin, E; Coucke, PA; Li, YX; Mirimanoff, RO; Ozsahin, M; Paschoud, N | 1 |
1 other study(ies) available for zalcitabine and Breast Neoplasms
| Article | Year |
|---|---|
Cell line specific radiosensitizing effect of zalcitabine (2',3'-dideoxycytidine).
Topics: Breast Neoplasms; Cell Cycle; Colonic Neoplasms; Flow Cytometry; Humans; Radiation-Sensitizing Agents; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Zalcitabine | 1997 |